Strategic review of $460m stake in Australian medical imaging company under way.
The Auckland drug maker introduces a dividend policy.
Listing the new fund is considered too problematic.
Tourism operator gives fresh profit guidance.
CEO responds to Simon Henry's comments about it and Nadia Lim.
The listed property company wants to improve value of ‘mispriced’ shares.
New Zealand's online shopping still trailing behind major economies.
CEO says nurse funding gap of $20-30,000pa between private and public sector.
The market has reacted positively to Ryman’s full-year results.
The company said it was a strong outcome for the times.